Residents of Pakistan’s tribal areas face dangerous obstacles to access HIV/AIDS treatment

NewsGuard 100/100 Score

"Having to contend with U.S. army drones and the crossfire between the Taliban and the Pakistani army, the residents of Pakistan's tribal areas find access to treatment for HIV/AIDS harder than in most other parts of the world," Inter Press Service reports. People with HIV/AIDS living "in the Federally Administered Tribal Areas (FATA) must cross the porous border into Afghanistan and take a circuitous route to Peshawar, capital of the Khyber Pakhtunkhwa province, to get timely anti-retroviral treatment (ART)," at a family care center established by the Pakistan government and the WHO, the news service writes.

"The WHO's Dr. Omar Ali says the government has been requested to facilitate access to FATA to provide treatment to the patients there, but there has been no response," the news service writes, adding, "Ali says the number of [people living with HIV/AIDS] was increasing because of intravenous drug use, lack of screening facilities in the blood banks, use of unsterilized equipment by dentists and recycling of disposable syringes" (Yusufzai 9/8).


http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Unveiling the key role of RNA modification in HIV-1 survival and replication